🇺🇸 FDA
Patent

US 11987586

Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonists

granted A61PA61P25/00A61P25/28

Quick answer

US patent 11987586 (Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonists) held by Takeda Pharmaceutical Company Limited expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P25/00, A61P25/28, A61P3/04